Alegre ML - Search Results

1

Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock.

Marchant A, Alegre ML, Hakim A, Piérard G, Marécaux G, Friedman G, De Groote D, Kahn RJ, Vincent JL, Goldman M. Marchant A, et al. Among authors: alegre ml. J Clin Immunol. 1995 Sep;15(5):266-73. doi: 10.1007/BF01540884. J Clin Immunol. 1995. PMID: 8537471

2

Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.

Schandené L, Vandenbussche P, Crusiaux A, Alègre ML, Abramowicz D, Dupont E, Content J, Goldman M. Schandené L, et al. Among authors: alegre ml. Immunology. 1992 May;76(1):30-4. Immunology. 1992. PMID: 1385797 Free PMC article.

3

Dopamine dependence in hypocalcemic patients.

Alegre M, Vincent JL. Alegre M, et al. Intensive Care Med. 1990;16(7):463-5. doi: 10.1007/BF01711228. Intensive Care Med. 1990. PMID: 2269717

4

Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.

Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Pinsky MR, et al. Chest. 1993 Feb;103(2):565-75. doi: 10.1378/chest.103.2.565. Chest. 1993. PMID: 8432155

5

Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor.

Alegre M, Vandenabeele P, Flamand V, Moser M, Leo O, Abramowicz D, Urbain J, Fiers W, Goldman M. Alegre M, et al. Eur J Immunol. 1990 Mar;20(3):707-10. doi: 10.1002/eji.1830200337. Eur J Immunol. 1990. PMID: 2138564

6

Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome.

Alegre ML, Gastaldello K, Abramowicz D, Kinnaert P, Vereerstraeten P, De Pauw L, Vandenabeele P, Moser M, Leo O, Goldman M. Alegre ML, et al. Transplantation. 1991 Oct;52(4):674-9. doi: 10.1097/00007890-199110000-00018. Transplantation. 1991. PMID: 1833865

7

Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice.

Wissing KM, Desalle F, Abramowicz D, Willems F, Leo O, Goldman M, Alegre ML. Wissing KM, et al. Among authors: alegre ml. Transplantation. 1999 Sep 15;68(5):677-84. doi: 10.1097/00007890-199909150-00014. Transplantation. 1999. PMID: 10507488

8

Emergence of Th2-like cells after anti-CD3 monoclonal antibody administration in mice.

Wissing M, Alegre ML, Abramowicz D, Willems F, Donckier V, Vanderhaeghen ML, Leo O, Goldman M. Wissing M, et al. Among authors: alegre ml. Transplant Proc. 1995 Feb;27(1):378-9. Transplant Proc. 1995. PMID: 7879027 No abstract available.

9

Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions.

Alegre M, Depierreux M, Florquin S, Najdovski T, Vandenabeele P, Abramowicz D, Leo O, Deschodt-Lanckman M, Goldman M. Alegre M, et al. Transplant Proc. 1990 Aug;22(4):1920-1. Transplant Proc. 1990. PMID: 2143864 No abstract available.

10

Downregulation of antigen-presenting cell functions after administration of mitogenic anti-CD3 monoclonal antibodies in mice.

Muraille E, Andris F, Pajak B, Wissing KM, De Smedt T, Desalle F, Goldman M, Alegre ML, Urbain J, Moser M, Leo O. Muraille E, et al. Among authors: alegre ml. Blood. 1999 Dec 15;94(12):4347-57. Blood. 1999. PMID: 10590081 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters